QUALCOMM INC (QCOM)
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Information Technology
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for QCOM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| QCOM | ["Executive Leadership", "Public Company Board Experience", "Technology Industry", "Accounting", "Finance", "Public Policy"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| HALO | ["Medicine and Science", "Pharma Business Leadership and Operations", "Complementary Business/Industry Segment Experience", "International Business", "Human Capital Management", "Finance and Capital Markets", "M&A", "Risk Management"] | [] | 2026 | ||
| BDX | Former Chief Financial Officer, Cardinal Health Inc.; Chair; President of JWH Consulting LLC | 61 | ["Experienced healthcare executive", "Deep knowledge of the industry", "Strong financial, strategic and operational expertise", "Significant international experience", "Valuable corporate governance experience", "Advisory Director to Berkshire Partners LLC", "Former Chief Financial Officer of Cardinal Health Inc.", "Held multiple positions at Eli Lilly and General Motors"] | ["Audit", "Compensation and Human Capital"] | 2025 |
Biography sourced from the proxy statement filing.
Mr. Henderson has been President of JWH Consulting LLC, a business and investment advisory firm, since January 2018. He served as an Advisory Director to Berkshire Partners LLC, a private equity firm, from September 2015 to December 2019. Mr. Henderson served as Chief Financial Officer of Cardinal Health Inc. from May 2005 to November 2014. Prior to joining Cardinal Health, he held multiple management positions at Eli Lilly including serving as President and General Manager of Eli Lilly Canada, and Controller and Treasurer of Eli Lilly Inc., as well as various management positions with General Motors, including in Great Britain, Singapore, Canada and the U.S. Mr. Henderson previously served as a director of FibroGen, Inc. from August 2015 to June 2024. Mr. Henderson holds a B.S. in Electrical Engineering from Kettering University and an M.B.A. from Harvard Business School. He has also earned a CERT Certificate in Cybersecurity Oversight from the Software Engineering Institute at Carnegie Mellon University. Mr. Henderson s qualifications to serve on our Board include his financial and operational executive management experience, including his significant experience in international operations, which is a source of valuable insights to our Board. His experience in senior operational and financial management positions at companies that experienced significant growth and transformation, including into additional business areas, also provides a useful resource to our senior management. Our Board and senior management also benefit from Mr. Henderson s experience from serving on other public company boards. He has been designated as an audit committee financial expert.